• On sale!
search

LACTULOSE THINK * OS 180ML66.7%

  • Towa Pharmaceutical S.p.A.
  • 034026043
Lattulosio Pensa is a drug based on the active ingredient lactulose (FU) (DC.IT) - belonging to the category of laxatives and specifically laxatives with osmotic action. Lattulosio Pensa can be prescribed with OTC Recipe - self-medication. Short-term treatment of occasional constipation
info_outline View product sheet
Final Price €7.09
Quantity
check_circle Available
Shipped within 24 h
  Convenient and safe payments

Even with a credit card

  Shipping in 24h all over the world

Fast and safe international shipping worldwide

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service. Experts in international shipping

Other products Others products at unbeatable price

Towa Pharmaceutical S.p.A.

Discover all products

LACTULOSE THINK * OS 180ML66.7%

Therapeutic indications

Short-term treatment of occasional constipation

Dosage and method of use

Adults: the average daily dosage is 10-15 g in two administrations. This dosage can be doubled or halved depending on the individual response or clinical picture.Children: from 2.5 to 10 g / day, even in a single dose, depending on the age and severity of the case.Infants: on average 2.5 g per day. LACTULOSE PENSA granules for oral solution can be administered dissolved in water or suitably diluted in milk or other drinks. Swallow with an adequate amount of water (a large glass). A diet rich in liquids favors the effect of the medicine. Lactulose is absorbed to a very small extent and has no caloric value. However, LACTULOSE PENSA contains, in addition to lactulose, also galactose, lactose and small quantities of other sugars. This must be taken into account in the treatment of diabetic patients and in patients on low calorie diets. The correct dose is the minimum sufficient to produce easy evacuation of soft stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Take preferably in the evening. Laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Laxatives are contraindicated in subjects with acute abdominal pain or of unknown origin, nasuea, vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration. Contraindicated in subjects with galactosemia

Side effects

Occasionally: isolated cramping pains or abdominal colic, more frequent in cases of severe constipation. Occasionally: flatulence.

Special warnings

Warnings.Do not use the drug if abdominal pain, nausea and vomiting are present. If constipation is persistent, consult a doctor. In patients presenting with disorders caused by excessive intestinal meteorism it is advisable to start treatment with the minimum doses indicated; these doses can be gradually increased in relation to the patient's response. The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In severe cases, the onset of dehydration or hypokalaemia (decrease in potassium in the blood) is possible, which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glucosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause addiction (and, therefore, the possible need to gradually increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Precautions for use The treatment of chronic or recurrent constipation always requires the intervention of the physician for the diagnosis, the prescription of drugs and the surveillance during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous bowel habits (frequency and characteristics of bowel movements) that has lasted for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable that elderly people or those in poor health conditions consult their doctor before using the medicine. In children under the age of 12, the medicine can only be used after consulting your doctor.

Pregnancy and breastfeeding

There are no adequate and well-controlled studies on the use of the drug in pregnancy or breastfeeding. Therefore, the medicine should only be used in case of need, under the direct supervision of the doctor, after evaluating the expected benefit to the mother in relation to the possible risk to the fetus or infant.

Expiration and retention

They are not provided.

Interactions with other drugs

Broad spectrum antibacterial agents, administered orally at the same time as lactulose, can reduce its degradation by limiting the possibility of acidification of the intestinal contents and consequently the therapeutic efficacy. Laxatives can reduce the time spent in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other drugs at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative.

Overdose

Excessive doses can cause abdominal pain and diarrhea, the resulting loss of fluids and electrolytes must be replaced. See also the information in the section “Special warnings and precautions for use” regarding the abuse of laxatives.

Active principles

180 ml bottle of syrup 100 ml of syrup contain: Active ingredient: Lactulose g 66.7 Sachet of 3 g A sachet of 3 g contains: Active ingredient: Lactulose g 3

Excipients

Syrup: Sodium benzoate 0.118 g, Purified water qba 100 ml Granulate for oral solution: orange flavor 21 mg

034026043

Data sheet

Packaging
66 -7 g / 100 ml syrup 180 ml
66.7 g / 100 ml syrup 180 ml
Product Type
HUMAN DRUG
ATC code
A06AD11
ATC description
Lactulose
Therapeutic Group
Laxatives
Active principle
lactulose (FU) (DC.IT)
Class
C.
Pharmaceutical form
syrup
Type of Administration
oral
Container
Flacone con misurino dosatore
bottle
Quantity
1 vial / vial / vial
Capacity
180 milliliters
Quantity of the Active Ingredient
667MG
Recipe required
OTC - self-medication medicine
chat Comments (0)